EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loss of POLE3-POLE4 unleashes replicative gap accumulation upon treatment with PARP inhibitors

Bethany Rebekah Hill, Meryem Ozgencil, Lauryn Buckley-Benbow, Sophie Louise Pamela Skingsley, Danielle Tomlinson, Carmen Ortueta Eizmendi, Alessandro Agnarelli, Roberto Bellelli

Cell Reports · 2024

DOI: 10.1016/j.celrep.2024.114205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Bethany Rebekah Hill und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Cell & Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, EC1M 6BQ London, UK. Hauptthemen laut MEDLINE: DNA Replication, Poly(ADP-ribose) Polymerase Inhibitors, DNA Polymerase III, DNA-Directed DNA Polymerase. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Barts Charity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA ReplicationPoly(ADP-ribose) Polymerase InhibitorsDNA Polymerase IIIDNA-Directed DNA PolymeraseDrug Resistance, NeoplasmHumansBRCA1 ProteinCell Line, TumorDNA Polymerase IIRad51 RecombinaseTumor Suppressor p53-Binding Protein 1DNA-Binding ProteinsNucleoproteins

Stichwörter der Autor:innen

CP: CancerCP: Molecular biologyPARP inhibitorsPOLE3-POLE4replicative gaps

Substanzen

BRCA1 ProteinDNA Polymerase IIPoly(ADP-ribose) Polymerase InhibitorsRad51 RecombinaseTumor Suppressor p53-Binding Protein 1DNA Polymerase IIIDNA-Directed DNA PolymerasePOLE3 protein, humanDNA-Binding ProteinsNucleoproteins

Autor:innen und Institutionen

  • Centre for Cancer Cell & Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, EC1M 6BQ London, UK.
  • Centre for Cancer Cell & Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, EC1M 6BQ London, UK. Electronic address: r.bellelli@qmul.ac.uk.

Förderung

  • Wellcome Trust
  • Medical Research Council
  • Barts Charity
  • UKRI Medical Research Council
  • Academy of Medical Sciences

Zitieren

APA

Hill, B. R., Ozgencil, M., Buckley-Benbow, L., Skingsley, S. L. P., Tomlinson, D., Eizmendi, C. O., Agnarelli, A., & Bellelli, R. (2024). Loss of POLE3-POLE4 unleashes replicative gap accumulation upon treatment with PARP inhibitors. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114205

Vancouver

Hill BR, Ozgencil M, Buckley-Benbow L, Skingsley SLP, Tomlinson D, Eizmendi CO, et al. Loss of POLE3-POLE4 unleashes replicative gap accumulation upon treatment with PARP inhibitors. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114205

BibTeX
@article{Hill2024,
  author = {Hill, Bethany Rebekah and Ozgencil, Meryem and Buckley-Benbow, Lauryn and Skingsley, Sophie Louise Pamela and Tomlinson, Danielle and Eizmendi, Carmen Ortueta and Agnarelli, Alessandro and Bellelli, Roberto},
  title = {Loss of POLE3-POLE4 unleashes replicative gap accumulation upon treatment with PARP inhibitors},
  journal = {Cell Reports},
  year = {2024},
  doi = {10.1016/j.celrep.2024.114205}
}
Kostenlos starten →